BioAegis Demonstrates Gelsolin Therapy Can Quell the Cytokine Storm and Promote Tissue Repair
27 avr. 2020 01h15 HE
|
BioAegis Therapeutics
MORRISTOWN, N.J., April 27, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. has highlighted recently published gene expression data in animal studies where recombinant human plasma gelsolin...
After Letter from Religious Liberty Law Firm, New York County Aligns Policies with First Amendment
23 avr. 2020 15h18 HE
|
First Liberty Institute
CHEMUNG, N.Y., April 23, 2020 (GLOBE NEWSWIRE) -- County officials in Chemung County, NY today stated that it will once again respect drive-in church services. The change came about a day after...
Screening of 11,552 Compounds Identifies Innovation Pharmaceuticals’ Brilacidin as One of the Most Promising Potential Inhibitors of the Novel Coronavirus COVID-19
20 avr. 2020 09h00 HE
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., April 20, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that based on molecular...
Developer of PharmaCyte Biotech’s COVID-19 Test Explains Why His Test Is So Highly Sensitive, Path to FDA EUA, and Commercialization
20 avr. 2020 09h00 HE
|
PharmaCyte Biotech
NEW YORK, NY, April 20, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) recently entered into a licensing agreement with Hai Kang Life Corporation (Hai Kang), where Hai Kang granted to...
Knoema Organizes Coalition of Alternative Data Providers to Support COVID-19 Knowledge Sharing and Policy Making
16 avr. 2020 08h42 HE
|
Knoema
New York, April 16, 2020 (GLOBE NEWSWIRE) -- Knoema, the provider of an end-to-end data and knowledge management platform and one of the largest global repositories of public data, is partnering...
PharmaCyte Biotech to Offer COVID-19 Testing While Creating Revenue Stream for Pancreatic Cancer Program
13 avr. 2020 09h00 HE
|
PharmaCyte Biotech
NEW YORK, NY, April 13, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) is a California-based biotechnology company focused on developing cellular therapies for cancer and diabetes using...
First Liberty Institute Demands Mississippi Mayor to Stop Targeting CDC “Drive-In” Churchgoers
09 avr. 2020 16h09 HE
|
First Liberty Institute
GREENVILLE, Miss., April 09, 2020 (GLOBE NEWSWIRE) -- First Liberty Institute today sent a letter to Greenville, Mississippi Mayor Errick Simmons urging him to withdraw an order that targets...
Innovation Pharmaceuticals in Discussions to Advance Brilacidin into Human Trials Against COVID-19
06 avr. 2020 07h30 HE
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., April 06, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB: IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today the Company is engaged in...
Small NJ Biotech Firm, BioAegis Therapeutics, Accelerating Multiple Clinical Trial Submissions for Severe COVID-19 Pneumonia Patients
02 avr. 2020 02h15 HE
|
BioAegis Therapeutics
MORRISTOWN, N.J., April 02, 2020 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. is a clinical stage, private company focused on developing therapies for infectious, inflammatory, and degenerative...
Innovation Pharmaceuticals Brilacidin to be Researched as Possible Novel Coronavirus (COVID-19) Vaccine; Brilacidin Now Being Tested as Drug and Vaccine at Different Institutions
17 mars 2020 07h30 HE
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., March 17, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today further details on the...